secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0000896264-25-000175
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA enters $75M revolving credit facility with Bank of America, $200M accordion option
--------------------------------------------------------------------------------

- New $75M revolver replaces prior agreement; includes $200M accordion feature subject to conditions.
- Interest on Term SOFR loans at Term SOFR plus 1.75%; commitment fee 0.25%.
- Financial covenants: minimum consolidated EBITDA of $80M (step-up to $100M after Q3 2026) and funded debt/EBITDA ≤ 2.0x.
- No restrictions on cash dividends or share repurchases under the credit agreement.
- Obligations secured by pledge of capital stock of subsidiaries via Amended and Restated Security and Pledge Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000175/0000896264-25-000175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000175/usna-20250627.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer